𝗥𝗲𝘁𝗵𝗶𝗻𝗸 𝟭𝗟 𝗛𝗥+/𝗛𝗘𝗥𝟮− Episode 3 | Ons Step Ahead

𝗥𝗲𝘁𝗵𝗶𝗻𝗸 𝟭𝗟 𝗛𝗥+/𝗛𝗘𝗥𝟮− Episode 3 | Ons Step Ahead Our experts explore how biomarker-based monitoring and serial ESR1 mutation testing can help clinicians detect resistance earlier, intervene proactively, and keep patients ahead of disease progression — with the goal of preserving quality of life for longer. 🎙️ Featuring: Dr. Hassan Jaafar Dr. Saeed Rafii Dr. Dina Hamza Dr. Hussam Marashi Endorsed by EOS | Supported by AstraZeneca | Managed by Conveners #BreastCancer #MetastaticBreastCancer #HRPositive #ESR1 #Biomarkers #Oncology #MedicalOncology #Conveners #EOS #AstraZeneca Follow us on Instagram:   / eos.uae.official     / conveners.me   Follow us on LinkedIn:   / dashboard     / dashboard